Control of detrusor hyperreflexia by the intravesical instillation of oxybutynine hydrochloride-Reference-Cited by-同舟云学术

Control of detrusor hyperreflexia by the intravesical instillation of oxybutynine hydrochloride

Published:1991-02 Issue:2 Volume:29 Page:84-90
ISSN:1362-4393
Container-title:Spinal Cord
language:en
Short-container-title:Spinal Cord

Author:

Madersbacher H,Jilg G

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology,General Medicine

Link

http://www.nature.com/articles/sc199111.pdf

Reference9 articles.

1. Brendler B C H, Radebaugh, L C, Mohler, J L 1989 Topical oxybutynin chloride for relaxation of dysfunctional bladders. Journal of Urology 141: 1350–1352.

2. Brindley G S, Polkey C E, Rushton D N 1982 Sacral anterior root stimulators for bladder control in paraplegia. Paraplegia 20: 365–381.

3. Diokno A C, Lapides J 1972 Oxybutynin: a new drug with analgesic and anticholinergic properties. Journal of Urology 108: 307–309.

4. Fredericks C M, Anderson G F Kreulen D L 1975 A study of the anticholinergic and antispasmodic activity of oxybutynin (Ditropan) on rabbit detrusor. Investigative Urology 12: 317–319.

5. Mulcahy J J, James H E McRoberts J W 1977 Oxybutynin chloride combined with intermittent clean catheterization in the treatment of myelomeningocele patients. Journal of Urology 118: 95–96.

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of neurogenic detrusor overactivity and overactive bladder with Botox (onabotulinumtoxinA): Development, insights, and impact;Medicine;2023-07-01

2. Treating Lower Urinary Tract Symptoms in Older Adults: Intravesical Options;Drugs & Aging;2023-03

3. Comprehensive overview of the available pharmacotherapy for the treatment of non-neurogenic overactive bladder in children;Expert Opinion on Pharmacotherapy;2022-05-06

4. Nanotechnology as a tool to advance research and treatment of non-oncologic urogenital diseases;Therapeutic Advances in Urology;2022-01

5. A Population Pharmacokinetic Model of (R)‐ and (S‐) Oxybutynin and Its Active Metabolites After Oral and Intravesical Administration to Healthy Volunteers;The Journal of Clinical Pharmacology;2021-01-13